AAV-8 is more efficient than AAV-9 in transducing neonatal dog heart

Human Gene Therapy Methods

Volumn 26, Issue 2, 2015, Pages 54-61

  Pan, Xiufang ^a   Yue, Yongping ^a   Zhang, Keqing ^a   Hakim, Chady H ^a   Kodippili, Kasun ^a   McDonald, Thomas ^a   Duan, Dongsheng ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS 8; ADENO ASSOCIATED VIRUS 9; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DOSAGE; GENETIC TRANSDUCTION; HEART; JUGULAR VEIN; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PUPPY; SKELETAL MUSCLE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS CAPSID; VIRUS GENOME; ANIMAL; CARDIAC MUSCLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLASSIFICATION; DEPENDOPARVOVIRUS; DOG; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; PLASMID; PROCEDURES; PROMOTER REGION;

ADENO-ASSOCIATED VIRUS; CANIS FAMILIARIS; MAMMALIA; MIRIDAE;

ANIMALS; ANIMALS, NEWBORN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DEPENDOVIRUS; DOGS; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; INJECTIONS, INTRAVENOUS; MALE; MUSCLE, SKELETAL; MYOCARDIUM; PLASMIDS; PROMOTER REGIONS, GENETIC; TRANSDUCTION, GENETIC;

EID: 84928151565     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2014.128     Document Type: Article

References (32)

1. Atchison RW, Casto BC, Hammon WM. Adenovirus-associated defective virus particles. Science 1965;149:754-756.
2. Vandenberghe LH, Wilson JM, Gao G. Tailoring the AAV vector capsid for gene therapy. Gene Ther 2009;16:311-319.
3. Kotterman M. A, Schaffer DV. Engineering adeno-associated viruses for clinical gene therapy. Nat Rev Genet 2014;15: 445-451.
4. Gregorevic P, Blankinship MJ, Allen JM, et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 2004;10:828-834.
5. Wang Z, Zhu T, Qiao C, et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 2005;23:321-328.
6. Pacak CA, Mah CS, Thattaliyath BD, et al. Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ Res 2006;99:e3-e9.
7. Inagaki K, Fuess S, Storm TA, et al. Robust systemic transductionwithAAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol Ther 2006;14:45-53.
8. Bostick B, Ghosh A, Yue Y, et al. Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration. Gene Ther 2007;14:1605-1609.
9. Gregorevic P, Allen JM, Minami E, et al. rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat Med 2006;12:787-789.
10. Shin JH, Pan X, Hakim C. H, et al. Microdystrophin ameliorates muscular dystrophy in the canine model of Duchenne muscular dystrophy. Mol Ther 2013;21:750-757.
11. Lai Y, Thomas GD, Yue Y, et al. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest 2009;119:624-635.
12. Goehringer C, Rutschow D, Bauer R, et al. Prevention of cardiomyopathy in delta-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors. Cardiovasc Res 2009;82:404-410.
13. Qiao C, Li J, Zhu T, et al. Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin. Proc Natl Acad Sci USA 2005;102: 11999-12004.
14. Xu R, DeVries S, Camboni M, Martin PT. Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice. Am J Pathol 2009;175:235-247.
15. Yue Y, Ghosh A, Long C, et al. A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. Mol Ther 2008; 16:1944-1952.
16. Pan X, Yue Y, Zhang K, et al. Long-term robust myocardial transduction of the dog heart from a peripheral vein by adenoassociated virus serotype-8. Hum Gene Ther 2013;24:584-594.
17. Fine DM, Shin JH, Yue Y, et al. Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs. Neuromuscul Disord 2011;21:453-461.
18. Smith BF, Yue Y, Woods PR, et al. An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed. Lab Invest 2011;91:216-231.
19. Shin JH, Yue Y, Duan D. Recombinant adeno-associated viral vector production and purification. Methods Mol Biol 2012;798:267-284.
20. Hakim C. H, Yue Y, Shin JH, et al. Systemic gene transfer reveals distinctive muscle transduction profile of tyrosine mutant AAV-1,-6, and-9 in neonatal dogs. Mol Ther Methods Clin Dev 2014;1:14002.
21. Gao GP, Alvira MR, Wang L, et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002;99:11854-11859.
22. Shin JH, Yue Y, Srivastava A, et al. A simplified immune suppression scheme leads to persistent micro-dystrophin expression in Duchenne muscular dystrophy dogs. Hum Gene Ther 2012;23:202-209.
23. Yue Y, Shin JH, Duan D. Whole body skeletal muscle transduction in neonatal dogs with AAV-9. Methods Mol Biol 2011;709:313-329.
24. Lai Y, Duan D. Progress in gene therapy of dystrophic heart disease. Gene Ther 2012;19:678-685.
25. Wasala NB, Shin JH, Duan D. The evolution of heart gene delivery vectors. J Gene Med 2011;13:557-565.
26. Nam HJ, Lane MD, Padron E, et al. Structure of adenoassociated virus serotype 8, a gene therapy vector. J Virol 2007;81:12260-12271.
27. DiMattia M. A, Nam HJ, Van Vliet K, et al. Structural insight into the unique properties of adeno-associated virus serotype 9. J Virol 2012;86:6947-6958.
28. Agbandje-McKenna M, Kleinschmidt J. AAV capsid structure and cell interactions. MethodsMol Biol 2011;807:47-92.
29. Chandrasekharan K, Yoon JH, Xu Y, et al. A humanspecific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy. Sci Transl Med 2010;2:42-54.
30. Leger A, Le Guiner C, Nickerson ML, et al. Adeno-associated viral vector-mediated transgene expression is independent of DNA methylation in primate liver and skeletal muscle. PLoS One 2011;6:e20881.
31. Everett RS, Evans HK, Hodges BL, et al. Strain-specific rate of shutdown of CMV enhancer activity in murine liver confirmed by use of persistent [E1(-), E2b(-)] adenoviral vectors. Virology 2004;325:96-105.
32. Weitzman MD, Linden RM. Adeno-associated virus biology. Methods Mol Biol 2011;807:1-23.